CNS Disorders Flashcards
what are the different methods of studying CNS disorders
imaging
post-mortem
indirect neuropharmacological markers
genetics-linkage analysis
animal models
what are the different imaging techniques for studying CNS disorders
computerized tomography - CT
Magnetic resonance imaging - MRI
functional MRI - fMRI
what is the spatial resolution of a CT scan
several mm
what is MRI technology based on an its spatial resolution
oxyhaemoglobin has a different magnetic resonance than deoxyhaemoglobin
less than 1mm
what is the basis of how fMRI’s work
visual stimulation utilises oxygen
microvasculature responds by increasing blood flows to specific brain regions
leads to increase in the oxyHb to deoxyHb ratio
function of diffusion tensor imaging
mapping pathways and investigating aberrant pathways
what is the difference between a PET and a SPET scan and what is the advantage and what do they both do
SPET uses single positron emissions and doesn’t need a cyclotron
reveal activity in the brain and estimate receptor levels
what are other non-invasive imaging techniques
electroencephalography
magnetoencephalography
when detecting for indirect markers where would you search
cerebrospinal fluid
plasma
urine
binding to platelets
what is an indirect marker for depression
platelet binding - binding to monoamine transporter
what are the disadvantages of using indirect markers for CNS disorders
proteins are labile - may degrade
patient may be taking medication
what does genetic-linkage analysis detect
RFLPs - restriction-fragment length polymorphisms
what does RFLPs require and what is its purpose in genetic-linkage analysis
requires family pedigree of the genetic disease
easiest to study in genetically isolated communities
detects whether the RFLPs and the disease are linked
why might genetic-linkage analysis using RFLPs not be effective with some diseases
may involve multiple genes
or involve mitochondrial DNA
what are the dis/advantages of using animal models
advantage - drug screening for therapies
disadvantage - not an exact phenocopy of the disease
where is ayahuasca derived from and what is the active psychomimetic ingredient
obtained from vines
harmaline
what is the active constituent in peyote
mescaline
why might lysergic acid diethylamide (LSD) be so potent
act very specifically at receptors sites in the brain
what does the cross-tolerance between LSD and mescaline suggest
they both act on the same class of receptor site
what is the structure of LSD and mescaline similar to
5-HT - seretonin